These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 808502)

  • 21. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
    Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
    Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Susceptibility of Pseudomonas aeruginosa isolated from hospital infections to antibiotics].
    Gniadkowski M; Skoczyńska A; Fiett J; Trzciński K; Hryniewicz W
    Pol Merkur Lekarski; 1998 Dec; 5(30):346-50. PubMed ID: 10101521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Origin and spread of Pseudomonas aeruginosa, Proteus and Klebsiella during twenty years in an infectious hospital.
    Petrás G; Bognár S
    Acta Microbiol Acad Sci Hung; 1981; 28(4):367-80. PubMed ID: 6797264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
    Sidorenko SV; Gel'fand EB; Mamontova OA
    Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of the resistance of hospital and nonhospital strains of Pseudomonas aeruginosa to antibacterial preparations].
    Krasil'nikov AP; Adarchenko AA; Krylov IA
    Antibiotiki; 1982 Jan; 27(1):25-9. PubMed ID: 6800301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Pseudomonas aeruginosa infection.
    Eykyn SJ
    Br J Hosp Med; 1984 Feb; 31(2):136-40. PubMed ID: 6421353
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudomonas aeruginosa isolates from different medical institutions.
    Nitzan Y; Sharon R; Maayan M; Steuerman C
    Isr J Med Sci; 1985 Oct; 21(10):798-803. PubMed ID: 3935600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibility and resistence of Pseudomonas aeruginosa to antimicrobial agents].
    Gamero Delgado MC; García-Mayorgas AD; Rodríguez F; Ibarra A; Casal M
    Rev Esp Quimioter; 2007 Jun; 20(2):230-3. PubMed ID: 17893761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.
    Tsukayama DT; van Loon HJ; Cartwright C; Chmielewski B; Fluit AC; van der Werken C; Verhoef J;
    Int J Antimicrob Agents; 2004 Oct; 24(4):339-45. PubMed ID: 15380258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
    Ahmad SI
    Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial consequences of antibiotic usage.
    Giamarellou H; Touliatou K; Koratzanis G; Petrikkos G; Kanellakopoulou K; Lelekis M; Pagona A; Tsagarakis J; Symeonides J; Falagas M
    Scand J Infect Dis Suppl; 1986; 49():182-8. PubMed ID: 3103210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects for the next anti-Pseudomonas drug.
    Page MG; Heim J
    Curr Opin Pharmacol; 2009 Oct; 9(5):558-65. PubMed ID: 19748829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contribution of Pseudomonas Aeruginosa strains to infections in patients of specialistic outpatients clinics of the SP ZOZ in Nidzica].
    Pszenna M; Rokosz A; Luczak M
    Med Dosw Mikrobiol; 2005; 57(4):417-24. PubMed ID: 16773835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro susceptibility patterns of some major respiratory tract pathogens in Nigeria to eleven selected antibiotics.
    Osoagbaka OU
    West Afr J Med; 1990; 9(4):264-71. PubMed ID: 2083203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa.
    Blahová J; Králiková K; Krcméry V; Mlynarcík D; Trupl J
    Acta Virol; 1997 Oct; 41(5):293-6. PubMed ID: 9607084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibiotic resistance of Pseudomonas aeruginosa: a fact and a problem at the University Hospital Center of Cocody (Abidjan)].
    Aka J; Dosso M; Michel G
    Med Trop (Mars); 1987; 47(1):53-9. PubMed ID: 3035318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current resistance in surgical infections and its development since 1970].
    Kunze M; Bernasowski A; Metzel D
    Zentralbl Chir; 1986; 111(12):735-8. PubMed ID: 3529749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of some antibiotics against Pseudomonas aeruginosa strains isolated from cancerous patients.
    Del Piano M; Nicosia R; La Palombara P; Chiarini F
    Boll Ist Sieroter Milan; 1984 Jul; 63(3):181-7. PubMed ID: 6095882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.